No they are not trying to flip shareholders and they are way short on the YES vote, IMO. Their postponements are laughable. Where are the overdue Fins, where are the accountants and their long lived asset report? Why are regulators not interfering?
Are they waiting on the NASS 2017? A FDA approval?